Drug recall · August 20, 2025
Belsomra recall
Why: Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpack and Print Mat Labels), 0006-0033-30 (Carton Label)
- Lots / codes
Lots 2090019 and 2123744, Exp. 4/30/2027
- Quantity
- 51,320 cartons
- Company
- Merck & Co. Inc, Rahway, NJ
- Distribution
- Nationwide in the USA and PR.
- Initiated
- July 21, 2025 · Voluntary: Firm initiated
- Classified
- August 13, 2025
- Reported
- August 20, 2025
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Belsomra
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.